Disease relevance of Thoracic Diseases

• PATIENTS OR PARTICIPANTS: Four patients with COPD and 10 patients with restrictive thoracic diseases with chronic hypercapnia (median baseline Paco(2), 55.1 mm Hg) were studied [1].

High impact information on Thoracic Diseases

• The 24 hour pH test was particularly useful in evaluating patients who were referred with other abdominal or thoracic disease and had, in addition, symptoms suggestive of gastroesophageal reflux on history [2].
• Commonly abused drugs that may play a role in causing thoracic disease include cocaine, opiates, and methamphetamine derivatives [3].
• OBJECTIVE: The purpose of this study was to determine if nonlinear registration of clinically acquired thoracic CT and FDG positron emission tomography (PET) data sets supports more detailed interpretation of metastatic thoracic disease when compared with interpretations from nonregistered PET studies [4].
• The concentration of serum soluble VCAM-1 was higher (850 +/- 298 ng/ml) in patients with aortic or thoracic disease than in the healthy volunteers (494 +/- 94 ng/ml) [5].
• Serum samples were collected from 31 patients with thymoma and 16 patients with nonmalignant thoracic disease before clinical treatment [6].

Chemical compound and disease context of Thoracic Diseases

• In the past year, there were a few additional reports of MR imaging in the diagnosis of thoracic disease, which include a multi-institutional study comparing MR imaging with CT and histopathologic correlative studies evaluating gadopentetate dimeglumine-enhanced MR imaging [7].
• We report here a patient with carcinoma of the cervix with recurrent abdominal and thoracic disease who was previously treated with concurrent cisplatin and radiation for local control of pelvic disease [8].

Gene context of Thoracic Diseases

• Drug therapy for RA can result in thoracic disease that is difficult to distinguish from the manifestations of RA itself [9].

References